Search

Pharmagest Interactive

Закрыт

0

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

Макс.

Ключевые показатели

By Trading Economics

Доход

-1.8M

17M

Продажи

7.2M

116M

P/E

Средняя по отрасли

16.213

Дивидендная доходность

3.08

Рентабельность продаж

14.879

Сотрудники

1,400

EBITDA

178M

116M

Дивиденды

By Dow Jones

Дивидендная доходность

Средняя по отрасли

3.08%

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-24M

583M

Предыдущая цена открытия

0

Предыдущая цена закрытия

0

Pharmagest Interactive График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

3 нояб. 2025 г., 21:44 UTC

Отчет

Vertex Pharmaceuticals Revenue Climbs on Demand for Cystic Fibrosis Drugs

3 нояб. 2025 г., 23:44 UTC

Обсуждения рынка

Nikkei May Rise on Weaker Yen, Hopes for Govt Econ Steps -- Market Talk

3 нояб. 2025 г., 23:34 UTC

Обсуждения рынка

Gold Edges Lower Amid Lingering Worry Over China's Ending of Tax Incentive -- Market Talk

3 нояб. 2025 г., 23:28 UTC

Отчет

Palantir Revenue Hits Another Record as Defense Work Booms -- 2nd Update

3 нояб. 2025 г., 23:24 UTC

Отчет

Correct: Grab Holdings Sees FY2025 Adj Ebitda $490M-$500.0M, Higher Than $460M-$480M Projected in 2Q >GRAB

3 нояб. 2025 г., 23:14 UTC

Обсуждения рынка
Приобретения, слияния, поглощения

Global Equities Roundup: Market Talk

3 нояб. 2025 г., 23:14 UTC

Обсуждения рынка
Приобретения, слияния, поглощения

Deterra's Next CEO Might Bring New Approach to Deals -- Market Talk

3 нояб. 2025 г., 23:12 UTC

Отчет

Grab Holdings Sees FY2025 Adj Ebitda $490-$500.0M, Higher Than $460M-$480M Projected in 2Q >GRAB

3 нояб. 2025 г., 23:09 UTC

Отчет

Grab Holdings 3Q 2Q Adj EBITDA $136.0M Vs. $90.0M>GRAB

3 нояб. 2025 г., 23:09 UTC

Отчет

Grab Holdings 3Q Net $17.0M Vs. Net $15.0M >GRAB

3 нояб. 2025 г., 23:09 UTC

Отчет

Grab Holdings 3Q Rev $873.0M Vs. $716.0M >GRAB

3 нояб. 2025 г., 23:06 UTC

Обсуждения рынка
Отчет

Palantir Execs Forecast Future of U.S. Workers In AI World -- Market Talk

3 нояб. 2025 г., 22:36 UTC

Обсуждения рынка
Отчет

Palantir's U.S. Commercial Business Booms as It Expands AI -- Market Talk

3 нояб. 2025 г., 22:31 UTC

Отчет

Franco-Nevada 3Q EPS $1.49 >FNV

3 нояб. 2025 г., 22:31 UTC

Отчет

Franco-Nevada 3Q Rev $487.7M >FNV

3 нояб. 2025 г., 22:24 UTC

Обсуждения рынка

Xero Bulls Expect Improving U.S. Momentum in 1H -- Market Talk

3 нояб. 2025 г., 22:19 UTC

Приобретения, слияния, поглощения

Starbucks Agrees to Sell Stake in China Business -- WSJ

3 нояб. 2025 г., 21:59 UTC

Обсуждения рынка

RBA Set To Keep Rates On Hold; Remain Data Dependent -- Market Talk

3 нояб. 2025 г., 21:54 UTC

Обсуждения рынка
Отчет

Westpac's Tech Challenge Keeps Jefferies Cautious -- Market Talk

3 нояб. 2025 г., 21:54 UTC

Обсуждения рынка
Отчет

Global Equities Roundup: Market Talk

3 нояб. 2025 г., 21:50 UTC

Обсуждения рынка

Basic Materials Roundup: Market Talk

3 нояб. 2025 г., 21:49 UTC

Отчет

Palantir Revenue Hits Another Record as Defense Work Booms -- Update

3 нояб. 2025 г., 21:40 UTC

Отчет

Barry Diller's IAC Inks AI Deal With Microsoft. That Isn't Why the Stock Is Sliding. -- Barrons.com

3 нояб. 2025 г., 21:31 UTC

Обсуждения рынка

Mexican Manufacturing Indexes Pick Up in October -- Market Talk

3 нояб. 2025 г., 21:19 UTC

Отчет

Palantir Revenue Hits Another Record as Defense Work Booms -- WSJ

3 нояб. 2025 г., 21:11 UTC

Приобретения, слияния, поглощения

Pfizer Reports Earnings Tuesday. Management Has Big Questions to Answer. -- Barrons.com

3 нояб. 2025 г., 21:11 UTC

Отчет

Diamondback Energy: Increasing Full Yr Oil Production Guidance to 495-498 MBO/d and Increasing Annual BOE Guidance to 910-920 MBOE/d >FANG

3 нояб. 2025 г., 21:07 UTC

Отчет

Palantir Technologies: Raising 2025 U.S. Comml Rev Guidance to in Excess of $1.433B, Representing a Growth Rate of at Least 104% >PLTR

3 нояб. 2025 г., 21:05 UTC

Отчет

Vertex Pharmaceutic Sees 2025 Rev $11.9B-$12B >VRTX

3 нояб. 2025 г., 21:05 UTC

Отчет

Palantir Technologies 3Q Net $475.6M >PLTR

Pharmagest Interactive Прогноз

Консенсус по рейтингу

By TipRanks

0 ratings

0

Покупка

0

Удержание

0

Продажа

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Pharmagest Interactive

Equasens Société anonyme provides healthcare IT solutions in Europe. The company develops electronic equipment, digital and robotic health, and equipment lease financing solutions. It also offers id., a pharmacy management software suite; id. PATIENT for the exchange of healthcare data; id. VENTE, which facilitates and secures prescription sales; id. COMMANDE, which manages orders and inventory; dispensing robots; Ségur id. services; FARMACLICK, a communication protocol; DIFARM, a modular solution for wholesalers-distributors; and PHARE, a retail management tool. In addition, the company offers patient medication adherence, patient loyalty, point-of-sale commercial performance, piloting pharmacy operations, pharmacy team training, securing pharmacy operations and health data, and digital communication solutions; and in-home nursing services and hospital-at-home, hospitals, and telemedicine solutions. Further, it provides id. DESK, an informative and interactive dashboard; id. UP!, a smartphone app; id. EASYQ, a queuing management solution; Miaterapia, a patient app; and MediStory for tracking patient records; ExpressVitale module; and MEDILINK, a health data hosting provider. Additionally, the company offers KAP&LINK2, a terminal with smart card and NFC reader; eS-KAP-Ad, a mobile device with a pre-loaded software; KAP-INSIDE, a mobile terminal; TI-KAP, which allows access to contact and contactless cards; AUTHENTIFICATEUR, a patented patient authentication system; KAP'TEUR by KAPELSE, a patented universal sensor; and NOVIAcare, which analyzes the behavior and activity of the elderly. It serves nursing homes, hospitals, in-house nursing care and hospital-at-home programs, regional health professional communities, multidisciplinary group practices, and individual healthcare professionals. The company was incorporated in 1996 and is headquartered in Villers-les-Nancy, France. Equasens Société anonyme is a subsidiary of Marque Verte Sante.
help-icon Live chat